- Details
- Description
Packaging Size:
4t/box
Strength:
5mg
Composition:
Entinostat
Treatment:
HR+, HER2-, locally advanced or metastatic breast cancer
Form:
Tablet
Brand:
景助达
Quantity Unit:
5mg*4t/box
Manufacturer:
EOC Pharma.,China
Entinostat is a synthetic drug that inhibits histone deacetylase (HDAC) enzymes.
- Entinostat sold as brand name 景助达® in china.
On April 30, 2024, Entinostat was approved in China for use in combination with an aromatase inhibitor for the treatment of patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2-negative (HER2-) locally advanced or metastatic breast cancer that has recurred or progressed after endocrine therapy.
